Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

(2019) Nicole J Polman et al.   LANCET ONCOLOGY

Primary cervical screening with high risk human papillomavirus testing: observational study

(2019) Matejka Rebolj et al.   BMJ-British Medical Journal

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60

(2017) Helena Lamin et al.   BMJ Open

Human papillomavirus test with cytology triage in organized screening for cervical cancer

(2016) Olga Veijalainen et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

(2014) K. M. Elfstrom et al.   BMJ-British Medical Journal

The HPV test has similar sensitivity but more overdiagnosis than the Pap test-A randomised health services study on cervical cancer screening in Finland

(2012) Nea Malila et al.   INTERNATIONAL JOURNAL OF CANCER

Randomised health services studies

(2012) Matti Hakama et al.   INTERNATIONAL JOURNAL OF CANCER

Randomized healthservices study of human papillomavirus-based management of low-grade cytological abnormalities

(2010) Lena Dillner et al.   INTERNATIONAL JOURNAL OF CANCER

Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test

(2008) G. Ronco et al.   JNCI-Journal of the National Cancer Institute